View Mobile Friendly Conference List »

“Excellent talks and networking. Good opportunity to talk to my peers from the pharmaceutical industry.”

Barbara Fox, PhD, CEO, Avaxia Biologics
Advisors

The Conference Forum Advisors

The Conference Forum is grateful for the guidance and support of the following outstanding leaders in the development and direction of its conferences:

  • Lee Allen, MD, PhD

    CMO

    Spectrum Pharmaceuticals

  • Lori Abrams

    Director, Diversity & Patient Engagement, R&D

    Bristol-Myers Squibb

  • Roy Baynes, MD, PhD

    SVP, Global Clinical Development

    Merck Research Labs

  • Zen Chu, MBA

    Faculty Director and Entrepreneur-In-Residence

    MIT

  • Lode Dewulf, MD

    VP and Chief Patient Officer

    UCB

  • Ken Getz, MBA

    Director of Sponsored Research / Founder

    Tufts CSDD / CISCRP

  • James Gulley, MD, PhD

    Head, Immunotherapy Section, Director, Medical Oncology Service, Office of the Clinical Director, Center for Cancer Research

    National Cancer Institute

  • Fred Hassan, MBA

    Managing Director, Healthcare

    Warburg Pincus

  • Axel Hoos, MD, PhD

    SVP, Oncology R&D

    GlaxoSmithKline

  • Anton Hoos, MD, PhD, MBA

    Head of Medical

    Amgen Europe

  • Michael Kalos, PhD

    CSO, Cancer Immunobiology

    Eli Lilly

  • Jeffrey Kasher, PhD

    Formerly VP, Clinical Innovation & Implementation

    Eli Lilly

  • Andreas Koester, MD, PhD

    VP, Clinical Trial Innovation & External Alliances

    Janssen

  • Thomas Koestler, PhD

    Executive Director, Health Care

    Vatera Health Care Partners

  • Craig Lipset, MBA

    Head of Clinical Innovation, R&D

    Pfizer, Inc.

  • Barbara Lueckel, PhD

    Global Business Development Director

    Roche

  • Lynn Marks, MD

    SVP, Projects, Clinical Platforms & Sciences

    GSK

  • Marilyn Metcalf, PhD

    Senior Director, Benefit Risk Evaluation

    GlaxoSmithKline

  • Linda Morgan

    Patient Representative, Research Advocate and Chair, Patients Advisory Council

    Parkinson's Disease Foundation

  • John Orloff, MD

    VP and Global Head of R&D

    Baxter BioSciences

  • Ülo Palm, MD, PhD, MBA

    SVP and Head Global Brands Drug Development Operations

    Actavis

  • Pamela Palmer, MD, PhD

    CMO and Co-Founder

    AcelRX Pharmaceuticals

  • Andrea Perrone, MD

    Head of Clinical Imaging, Translational Medicine

    Merck Research Labs

  • Julia Rashba-Step, PhD

    Senior Director, Novel Delivery Technologies

    Pfizer BioTherapeutics

  • Jeanne Regnante, MS

    Office of the Chief Medical Officer, Executive Director and Chief of Staff

    Merck

  • Tomasz Sablinski, MD, PhD

    CEO

    Transparency Life Sciences

  • Suzanne Schrandt, JD

    Deputy Director, Patient Engagement

    PCORI

  • Mark Simon, MBA

    Partner

    Torreya Partners

  • Komathi Stem

    Strategic Innovation Leader

    Genentech/Roche

  • Peter Thompson, MD, FACP

    Private Equity Partner

    OrbiMed Advisors

  • Veronica Todaro

    VP, National Programs

    Parkinson’s Disease Foundation

  • Jocelyn Ulrich, MPH

    Senior Director, Scientific and Regulatory Affairs

    PhRMA

  • Steven Zelenkofske, DO

    VP, Cardiovascular Medical Affairs Therapeutic Area Head

    AstraZeneca